Free Trial
NASDAQ:BCPC

Balchem (BCPC) Stock Price, News & Analysis

Balchem logo
$172.59 -1.44 (-0.83%)
Closing price 04:00 PM Eastern
Extended Trading
$172.52 -0.07 (-0.04%)
As of 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Balchem Stock (NASDAQ:BCPC)

Key Stats

Today's Range
$171.69
$174.59
50-Day Range
$154.22
$174.03
52-Week Range
$137.69
$186.03
Volume
138,035 shs
Average Volume
131,896 shs
Market Capitalization
$5.61 billion
P/E Ratio
43.92
Dividend Yield
0.50%
Price Target
$190.00
Consensus Rating
Moderate Buy

Company Overview

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Balchem Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
88th Percentile Overall Score

BCPC MarketRank™: 

Balchem scored higher than 88% of companies evaluated by MarketBeat, and ranked 34th out of 193 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Balchem has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Balchem has only been the subject of 2 research reports in the past 90 days.

  • Read more about Balchem's stock forecast and price target.
  • Earnings Growth

    Earnings for Balchem are expected to grow by 10.99% in the coming year, from $4.64 to $5.15 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Balchem is 43.92, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.60.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Balchem is 43.92, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 101.01.

  • Price to Earnings Growth Ratio

    Balchem has a PEG Ratio of 4.41. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Balchem has a P/B Ratio of 4.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Balchem's valuation and earnings.
  • Percentage of Shares Shorted

    1.38% of the float of Balchem has been sold short.
  • Short Interest Ratio / Days to Cover

    Balchem has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Balchem has recently increased by 7.03%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Balchem has a dividend yield of 0.50%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Balchem has been increasing its dividend for 16 years.

  • Dividend Coverage

    The dividend payout ratio of Balchem is 22.14%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Balchem will have a dividend payout ratio of 16.89% next year. This indicates that Balchem will be able to sustain or increase its dividend.

  • Read more about Balchem's dividend.
  • Percentage of Shares Shorted

    1.38% of the float of Balchem has been sold short.
  • Short Interest Ratio / Days to Cover

    Balchem has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Balchem has recently increased by 7.03%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Balchem has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.42 average news sentiment score of Basic Materials companies.
  • News Coverage This Week

    MarketBeat has tracked 28 news articles for Balchem this week, compared to 5 articles on an average week.
  • Search Interest

    1 people have searched for BCPC on MarketBeat in the last 30 days.
  • MarketBeat Follows

    2 people have added Balchem to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Balchem insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.25% of the stock of Balchem is held by insiders.

  • Percentage Held by Institutions

    87.91% of the stock of Balchem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Balchem's insider trading history.
Receive BCPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter.

BCPC Stock News Headlines

HC Wainwright Issues Negative Estimate for Balchem Earnings
Balchem (NASDAQ:BCPC) Upgraded by Sidoti to Hold Rating
The Deep State Surveillance Plot To Sabotage President Trump
There's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your retirement savings into a private safe-haven, free of chaos and market manipulation.
Equities Analysts Issue Forecasts for Balchem Q4 Earnings
Balchem (NASDAQ:BCPC) Stock Rating Lowered by StockNews.com
Sidoti Csr Issues Optimistic Estimate for Balchem Earnings
Sidoti Reaffirms Their Hold Rating on Balchem (BCPC)
See More Headlines

BCPC Stock Analysis - Frequently Asked Questions

Balchem's stock was trading at $162.99 on January 1st, 2025. Since then, BCPC stock has increased by 5.9% and is now trading at $172.59.
View the best growth stocks for 2025 here
.

Balchem Co. (NASDAQ:BCPC) released its quarterly earnings results on Friday, February, 21st. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.11 by $0.08. The basic materials company earned $240 million during the quarter, compared to analysts' expectations of $239.96 million. Balchem had a net margin of 13.47% and a trailing twelve-month return on equity of 11.37%.

Balchem subsidiaries include these companies: Zumbro River Brand Inc., Chemogas Holding NV, Bioscreen technologies, Innovative Food Processors, Chol-Mix Kft, Albion Laboratories Inc., SensoryEffects, and others.

Balchem's top institutional shareholders include Vanguard Group Inc. (12.19%), APG Asset Management N.V. (5.98%), Wasatch Advisors LP (3.70%) and Conestoga Capital Advisors LLC (3.61%). Insiders that own company stock include Theodore L Harris, David B Fischer, Gunsteren Job Leonard Van, William A Backus and Michael Robert Sestrick.
View institutional ownership trends
.

Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Balchem investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

Ex-Dividend for 1/17 Dividend
12/26/2024
Dividend Payable
1/17/2025
Last Earnings
2/21/2025
Today
3/03/2025
Next Earnings (Estimated)
5/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Chemicals & allied products
Sub-Industry
Specialty Chemicals
Current Symbol
NASDAQ:BCPC
CIK
9326
Employees
1,302
Year Founded
1967

Price Target and Rating

Average Stock Price Target
$190.00
High Stock Price Target
$190.00
Low Stock Price Target
$190.00
Potential Upside/Downside
+10.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
43.92
Forward P/E Ratio
37.20
P/E Growth
4.41
Net Income
$128.48 million
Pretax Margin
17.45%

Debt

Sales & Book Value

Annual Sales
$953.68 million
Cash Flow
$5.72 per share
Price / Cash Flow
30.17
Book Value
$35.37 per share
Price / Book
4.88

Miscellaneous

Free Float
32,102,000
Market Cap
$5.61 billion
Optionable
Optionable
Beta
0.69

Social Links

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NASDAQ:BCPC) was last updated on 3/3/2025 by MarketBeat.com Staff
From Our Partners